|
1
|
Sathornsumetee S and Rich JN: New
treatment strategies for malignant gliomas. Expert Rev Anticancer
Ther. 6:1087–1104. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Preusser M, Lim M, Hafler DA, Reardon DA
and Sampson JH: Prospects of immune checkpoint modulators in the
treatment of glioblastoma. Nat Rev Neurol. 11:504–514. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Floyd JA, Galperin A and Ratner BD: Drug
encapsulated polymeric microspheres for intracranial tumor therapy:
A review of the literature. Adv Drug Deliv Rev. 91:23–37. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Westphal M and Lamszus K: Circulating
biomarkers for gliomas. Nat Rev Neurol. 11:556–566. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jonas S and Izaurralde E: Towards a
molecular understanding of microRNA-mediated gene silencing. Nat
Rev Genet. 16:421–433. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu LF, Gasteiger G, Yu IS, Chaudhry A,
Hsin JP, Lu Y, Bos PD, Lin LL, Zawislak CL, Cho S, et al: A Single
miRNA-mRNA interaction affects the immune response in a context-
and cell-type-specific manner. Immunity. 43:52–64. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng L, Pu J, Qi T, Qi M, Li D, Xiang X,
Huang K and Tong Q: miRNA-145 targets v-ets erythroblastosis virus
E26 oncogene homolog 1 to suppress the invasion, metastasis, and
angiogenesis of gastric cancer cells. Mol Cancer Res. 11:182–193.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yuan Z, Ding S, Yan M, Zhu X, Liu L, Tan
S, Jin Y, Sun Y, Li Y and Huang T: Variability of miRNA expression
during the differentiation of human embryonic stem cells into
retinal pigment epithelial cells. Gene. 569:239–249. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu G, Li H, Wang J, Gumireddy K, Li A, Yao
W, Tang K, Xiao W, Hu J, Xiao H, et al: miRNA-34a suppresses cell
proliferation and metastasis by targeting CD44 in human renal
carcinoma cells. J Urol. 192:1229–1237. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang H, Yan C, Shi X, Zheng J, Deng L,
Yang L, Yu F, Yang Y and Shao Y: MicroRNA-575 targets BLID to
promote growth and invasion of non-small cell lung cancer cells.
FEBS Lett. 589:805–811. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Huang W, Ran Y, Xiong Y, Zhong Z,
Fan X, Wang Z and Ye Q: miR-582-5p inhibits proliferation of
hepatocellular carcinoma by targeting CDK1 and AKT3. Tumour Biol.
36:8309–8316. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang X, Hu C, Arnovitz S, Bugno J, Yu M,
Zuo Z, Chen P, Huang H, Ulrich B, Gurbuxani S, et al: miR-22 has a
potent anti-tumour role with therapeutic potential in acute myeloid
leukaemia. Nat Commun. 7:114522016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Y, Tang X, He Q, Yang X, Ren X, Wen X,
Zhang J, Wang Y, Liu N and Ma J: Overexpression of mitochondria
mediator gene TRIAP1 by miR-320b loss is associated with
progression in nasopharyngeal carcinoma. PLoS Genet.
12:e10061832016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang H, Cao F, Li X, Miao HEJ, Xing J and
Fu CG: miR-320b suppresses cell proliferation by targeting c-Myc in
human colorectal cancer cells. BMC Cancer. 15:7482015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Batistela MS, Josviak ND, Sulzbach CD and
de Souza RL: An overview of circulating cell-free microRNAs as
putative biomarkers in Alzheimer's and Parkinson's Diseases. Int J
Neurosci. Jul 20–2016.(Epub ahead of print). PubMed/NCBI
|
|
17
|
Hsu YC, Chang PJ, Ho C, Huang YT, Shih YH,
Wang CJ and Lin CL: Protective effects of miR-29a on diabetic
glomerular dysfunction by modulation of DKK1/Wnt/β-catenin
signaling. Sci Rep. 6:305752016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tana C, Giamberardino MA and Cipollone F:
microRNA profiling in atherosclerosis, diabetes and migraine. Ann
Med. 49:93–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bao MH, Li JM, Luo HQ, Tang L, Lv QL, Li
GY and Zhou HH: NF-κB-regulated miR-99a modulates endothelial cell
inflammation. Mediators Inflamm. 2016:53081702016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ke Y, Zhao W, Xiong J and Cao R: miR-149
inhibits non-small-cell lung cancer cells EMT by targeting FOXM1.
Biochem Res Int. 2013:5067312013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cui F, Wang S, Lao I, Zhou C, Kong H,
Bayaxi N, Li J, Chen Q, Zhu T and Zhu H: miR-375 inhibits the
invasion and metastasis of colorectal cancer via targeting SP1 and
regulating EMT-associated genes. Oncol Rep. 36:487–493.
2016.PubMed/NCBI
|
|
22
|
Shi H, Ji Y, Zhang D, Liu Y and Fang P:
MiR-135a inhibits migration and invasion and regulates EMT-related
marker genes by targeting KLF8 in lung cancer cells. Biochem
Biophys Res Commun. 465:125–130. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Babae N, Bourajjaj M, Liu Y, Van Beijnum
JR, Cerisoli F, Scaria PV, Verheul M, Van Berkel MP, Pieters EH,
Van Haastert RJ, et al: Systemic miRNA-7 delivery inhibits tumor
angiogenesis and growth in murine xenograft glioblastoma.
Oncotarget. 5:6687–6700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuan J, Xiao G, Peng G, Liu D, Wang Z,
Liao Y, Liu Q, Wu M and Yuan X: miRNA-125a-5p inhibits glioblastoma
cell proliferation and promotes cell differentiation by targeting
TAZ. Biochem Biophys Res Commun. 457:171–176. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Varamo C, Occelli M, Vivenza D, Merlano M
and Nigro Lo C: MicroRNAs role as potential biomarkers and key
regulators in melanoma. Genes Chromosomes Cancer. 56:3–10. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ebrahimi S, Ghasemi F, Hassanian SM,
Shahidsales S, Maftouh M, Akbarzade H, Parizadeh SA, Hassanian SM
and Avan A: Circulating microRNAs as novel potential diagnostic and
prognosis biomarkers in pancreatic cancer. Curr Pharm Des.
22:6444–6450. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kurozumi A, Goto Y, Okato A, Ichikawa T
and Seki N: Aberrantly expressed microRNAs in bladder cancer and
renal cell carcinoma. J Hum Genet. 62:49–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yan S, Wang T, Huang S, Di Y, Huang Y, Liu
X, Luo Z, Han W and An B: Differential expression of microRNAs in
plasma of patients with prediabetes and newly diagnosed type 2
diabetes. Acta Diabetol. 53:693–702. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang R, Qin Y, Zhu G, Li Y and Xue J: Low
serum miR-320b expression as a novel indicator of carotid
atherosclerosis. J Clin Neurosci. 33:252–258. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qin W, Tang Y, Yang N, Wei X and Wu J:
Potential role of circulating microRNAs as a biomarker for
unexplained recurrent spontaneous abortion. Fertil Steril.
105:1247–1254.e3. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tadano T, Kakuta Y, Hamada S, Shimodaira
Y, Kuroha M, Kawakami Y, Kimura T, Shiga H, Endo K, Masamune A, et
al: MicroRNA-320 family is downregulated in colorectal adenoma and
affects tumor proliferation by targeting CDK6. World J Gastrointest
Oncol. 8:532–542. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou J, Zhang M, Huang Y, Feng L, Chen H,
Hu Y, Chen H, Zhang K, Zheng L and Zheng S: MicroRNA-320b promotes
colorectal cancer proliferation and invasion by competing with its
homologous microRNA-320a. Cancer Lett. 356B:669–675. 2015.
View Article : Google Scholar
|
